Human γδ T cells comprise a first line of defense through TCR recognition of stressed cells. However, the molecular determinants and stress pathways involved in this recognition are largely unknown. Here we show that exposure of tumor cells to various situations of stress induced tumor cell recognition by a Vγ8Vδ3 TCR. Using a strategy that we previously developed to identify antigenic ligands of γδ TCRs (Willcox et al, Nat Immunol, 2012, 13:872), Annexin A2 was identified as the direct ligand of Vγ8Vδ3 TCR, and was found to be expressed on tumor cells upon the stress situations tested in a reactive-oxygen species-dependent manner. Moreover, purified Annexin A2 was able to stimulate the proliferation of a Vδ2neg γδ T cell subset within PBMC incubated with IL-2 and other Annexin A2-specific Vδ2neg γδ T cell clones could be derived from PBMC. We thus propose membrane exposure of Annexin A2 as an oxidative stress signal for some Vδ2neg γδ T cells that could be involved in an adaptive lymphoid stress surveillance.
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Introduction:
It is well established that one of the major roles of conventional αβ T lymphocytes is to protect the host against microorganisms. The molecular cornerstone of this function is the recognition by their antigen receptor of microbial moieties presented in the context of classical MHC molecules (1) . In contrast, γδ T lymphocytes do not recognize peptides presented by classical MHC molecules and are biased against self-reactive recognition. Consistent with the Ig-like structure of γδ TCRs (2) and the diversity of their repertoire, the self-antigens so far described to be directly recognized by γδ TCRs are structurally highly diverse, including MHCrelated or unrelated molecules (for recent reviews see (3) and (4)). Intriguingly, most of those self-antigens are constitutively expressed on cells and healthy tissues, implying mechanisms to control the γδ T cell response in appropriate situations and avoid autoimmunity. Some of these mechanisms have been described such as increased self-antigen expression upon cell activation (e.g T10/T22 in mice, (5) ), dependence of recognition on a multimolecular stress signature in CMV-infected cells and tumor cells (EPCR (6)), presentation of, or conformational modification by, metabolites (CD1d (7, 8) and BTN3A1 (9) (10) (11) ), and ectopic localization in tumor cells (F1-ATPase/ApoI (12) ).
Although the pathophysiological contexts associated with the expression of these self-antigens in the appropriate environment or conformation leading to γδ T cell response remains elusive for most of them, the contribution of γδ T cells to host protection is thought to rely on recognition of cell dysregulation. The socalled lymphoid stress surveillance response has been described as rapid, weakly specific and resulting from activation of large numbers of pre-activated or pre-programmed γδ T cells without necessary clonal expansion (13) . Stress surveillance by γδ T cells is considered important for tissue repair (14) , rapid local containment of microbes or tumors (15) (16) (17) , and activation of downstream conventional immune responses (18) .
Given their implication in the control of tumors and infections, understanding the molecular basis of stress surveillance by γδ T cells could have important impacts on their use in immunotherapy. Such understanding has been hindered by the limited characterization of bona fide stress-induced antigens recognized by γδ TCRs and of the stress pathways leading to the expression of these antigens. The objective of the present study was to provide novel insights into these issues. We focused on Vδ2 neg γδ T cell clones isolated from healthy donors previously shown to react against a broad panel of B cell lymphoma in an ILT-2-dependent pathway (19) . We elucidated here the antigenic specificity of one of these clones as being Annexin A2, a molecule expressed on the cell surface in response to oxidative stress and able to activate a subset of Vδ2 neg γδ T cells.
Results: Expression of 73R9 ligand by U373MG glioblastoma cell line
We focused on the Vγ8Vδ3 T cell clone (73R9) that was reactive against transformed B cells (19) . HLA-I engagement on 73R9 by ILT2 expressed on B cells was previously shown Significance Human γδ T lymphocytes have both innate-like and adaptivelike functions and can circulate in blood or reside in tissues. They are activated by specific antigens recognized by their TCR and recognize infected and transformed cells, suggesting that cellular stress is involved in specific antigen expression. However, molecular characterization of stress-induced antigens remains elusive, hampering our understanding of γδ T cell role cancer and infections. In the present study we identify Annexin A2 as such stress-induced antigen known as a phospholipidbinding protein involved in tumorigenesis, redox potential regulation and wound healing. Stress-mediated membrane exposure of Annexin A2 could thus constitute a novel danger signal for γδ T cells to recognize various cell dysregulations and protect the host against cancer and infections. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68 www.pnas.org ------PNAS Issue Date Volume Issue Number 1--?? to stimulate clone cytolytic function (19) . However, the role of the TCR in 73R9 recognition of B cells remained unclear. To address this issue we transduced the 73R9 TCR into the TCRdeficient human JRT3 T cell, producing the JRT3-73R9 reporter cell line. Unexpectedly, when assayed against transformed B cell lines the activation of JRT3-73R9 was markedly low ( Fig 1A) , except against the 721-221 cell line. Among forty-two other tumor cell lines tested, only the U373MG glioblastoma cell line induced a strong JRT3-73R9 cell activation, which was TCR-specific since not observed with other Vδ3 TCRs and inhibited by blocking anti-Vδ3 chain mAb ( Fig. 1A -C). Two other glioblastoma cell lines (U343MG and U251MG) also weakly induced JRT3-73R9 cell activation ( Fig. 1A) . Altogether, our results suggested that, by contrast to transformed B cells, the U373MG cell line expressed an antigen specifically recognized by the 73R9 TCR.
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Generation of a mAb specifically blocking 73R9 TCR reactivity
To characterize 73R9 TCR antigenic ligand, we generated a specific blocking monoclonal antibody using the strategy we previously described (6) . Mice were immunized with U373MG and B cell hybridoma supernatants screened for their ability to decrease JRT3-73R9 reactivity against U373MG. Such a hybridoma was selected and cloned to produce a mAb called FMS-01 ( Fig. 1D ). Inhibition by FMS-01 was specific for the Vγ8Vδ3 TCR as it was not observed for other γδ TCRs ( Fig 1E) . Among glioblastoma, U373MG was the cell line constitutively expressing the most important level of antigen labelled by FMS-01 mAb ( Fig. S1A ), in accordance with JRT3-73R9 reactivity (Fig. 1A ). We concluded that FMS-01 competed 73R9 TCR and most likely recognized the same antigen.
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Fig. 3. Stress stimulation of U343MG cells increases FMS-01 expression and 73R9 TCR reactivity(A-C)
U343MG monolayers were cultured from 24h to 168h in 0.1% O 2 atmosphere, then detached, counted and stained or incubated with T cells in normoxia. (D) U343MG monolayers were harvested at 60% (low confluence) or 100% (high confluence) of confluence prior to counting and incubation with JRT3-73R9. (E) U343MG cells were exposed to 42°C from 5 to 120 min prior to incubation with JRT3-73R9. CD69 expression by JRT3-73R9 (A, D, E) or CD107a expression by clone 73R9 (B) were evaluated after co-culture at 1:1 ratio for 4h with pre-treated U343MG cells, in the absence or presence of FMS-01 mAb. In cell-mediated activation of JRT3-73R9 when increasing B cell: JRT3-73R9 ratio (Fig. S1C ). Altogether, these results indicated that the same γδ T cell clone can use either TCR-dependent or independent molecular pathways of activation to respond to different target cells.
CMV-induced 73R9 TCR activation through up-regulation of FMS-01 ligand expression
Our previous studies demonstrated that some Vδ2 neg γδ T cells exhibit dual TCR-dependent reactivity against tumour cell lines and CMV-infected cells (20) . In accordance with this, CMV infection of U373MG and U343MG, but not that of U251MG, significantly upregulated 73R9 activation ( Fig. 2A ). This effect of CMV was TCR-dependent since observed also when using JRT3-73R9 ( Fig. 2B ), since inhibited by FMS-01 mAb ( Fig. 2C ) and since associated to increased FMS-01 ligand expression on U373MG (Fig. 2D ). These results supported the hypothesis that CMV-induced stress in host cells increased antigenic ligand expression and subsequent TCR-mediated activation of γδ T cells.
Different cell stress conditions trigger 73R9 TCR reactivity
We then investigated other conditions of cellular stress that could modulate target cell recognition by γδ T cells. First, preincubation of U343MG in hypoxia (0.1% O 2 ) induced both JRT3-73R9 and 73R9 clone reactivity when compared to pre-incubation in normoxia ( Fig. 3A and 3B ) (all activation assays were done at 21% O 2 , 37°C and with same number of target cells). JRT3 transduced with other γδ TCRs did not respond to hypoxia treated glioblastoma cells. Hypoxia-induced JRT3-73R9 and 73R9 clone activation was inhibited by FMS-01 mAb ( Fig. 3A and 3B) and associated to increased FMS-01 ligand expression on U373MG cells ( Fig. 3C ), suggesting γδ TCR-mediated stress sensing. Similar results were obtained when U343MG were pre-exposed to high confluence ( Fig. 3D and Fig. S2A TCR 73R9 activation always consistently correlated with FMS-01 staining on the target cell surface for each of these stress conditions (Table S1 ). Oxydative burst could be a common trigger to induce FMS-01 ligand expression because treating glioblastoma cells with the free radical scavenger N-Acetyl-L-Cysteine (NAC) during stress exposure partially inhibited the increased FMS-01 ligand expression by all stress conditions tested on the three glioblastoma cell lines ( Fig. 3F-H) . In conclusion, different cell stress conditions enhance γδ TCR-mediated sensing of target cells through an increased expression of membrane ligand which is at least partially dependent on ROS production.
Identification of Annexin A2 as the ligand for FMS-01 mAb
The nature of the membrane moiety bound by FMS-01 was then identified through immunoprecipitation. FMS-01 specifically immunoprecipitated a protein of approximately 35 kDa from all glioblastoma cell lysates but not from a FMS-01-negative control cell line ( Fig 4A) . Proteins contained within the specific ∼35 kDa band were digested with trypsin and analysed by Fourier transform-ion-cyclotron resonance mass spectrometry. This identified Annexin A2, a 35 kDa intracellular protein known to bind anionic phospholipids in a Ca 2+ -dependent manner, and to translocate to the cell surface as a heterotetrameric complex with the 11 kDa protein S100A10 (21) . In line with this, FMS-01 staining strongly correlated with S100A10 expression in different cell types (Fig. 4B) . Moreover, proteins immunoprecipitated with FMS-01 mAb were also detected with anti-Annexin A2 and anti-S100A10 mAbs by western-blots ( Fig S3A) . Western blots using recombinant forms of both proteins, or U373MG EGTA eluates containing Annexin A2/S100A10 complex from the cell surface as previously shown (21) Deora 2004, demonstrated that FMS-01 bound Annexin A2 only ( Fig 4C) . Finally, downregulation of Annexin A2 or S100A10 expression in glioblastoma cell lines using specific sh-RNA showed that surface staining by FMS-01   273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340   Footline Author  PNAS  Issue Date  Volume  Issue Number  3   341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408 Submission PDF was dependent on Annexin A2 expression but independent of S100A10 expression ( Fig 4D and Fig S3B) . Annexin A2 is recognized by the 73R9 TCR FMS-01 ligand was expected to be 73R9 TCR ligand, it was then important to ensure that 73R9 TCR recognized Annexin A2. EGTA membrane eluates from U373MG cells cultured at high confluence were able to activate JRT3-73R9, and not other TCRtransductants, in an Annexin A2-dependent manner, in contrast to eluates generated from cells cultured at low confluence ( Fig.  5A and S4A ). Annexin A2 was mandatory for recognition of glioblastoma cells by JRT3-73R9 since down regulation of its expression by RNA interference abrogated JRT3-73R9 activation while downregulation of S100A10 had no effect ( Fig 5B) . Remarkably, recombinant soluble Annexin A2 alone, but not recombinant S100A10, was able to activate very efficiently JRT3-73R9 ( Fig. 5C left panel) . Activation was not observed when using Annexin A6 (Fig 5C right panel) or another TCR-transductant ( Fig S4B) , and was inhibited in the presence of the FMS-01 mAb ( Fig S4C) . Moreover, soluble Annexin A2 was at least as efficient as anti-CD3 mAb to activate the 73R9 clone ( Fig 5D) . Finally, Annexin A2, but not A6, was able to induce multiple functions on the clone such as cytotoxicity (assessed by CD107a expression and granzyme B production) but also TNFα, IFNγ and GM-CSF secretion ( Fig 5D) .
Molecular interaction between Annexin A2 and the 73R9 TCR was then confirmed by surface plasmon resonance (SPR). We observed greater responses when recombinant Annexin A2 was injected over immobilized 73R9 TCR compared to control TCRs or streptavidin alone, indicating specific binding ( Fig 5E) . Equilibrium binding analyses yielded an apparent dissociation constant (Kd) of ∼3μM ( Fig S4D) . No specific binding of Annexin A6 was observed to 73R9 TCR when compared to control TCR. Annexin A2 was not only binding but also signalling through the TCR since ERK 1/2 and SLP76 phosphorylation was induced in the 73R9 clone ( Fig 5F) -but not control clone ( Fig  S4E) -as well as in the JRT3-73R9 -but not in a control transductant -( Fig S4F) . Altogether, these results provide evidence that the 73R9 TCR directly recognizes Annexin A2 independently of S100A10. Annexin A2 translocation to the cell surface represents a unified stress signal recognized by this TCR.
Annexin A2 induces the proliferation of a Vδ2 neg γδ T cell subset
Finally, we tested the effect of Annexin A2 on Vδ2 neg γδ T cells isolated from the blood of healthy donors. When cocultured with autologous PBMC, a small population of proliferating Vδ2 neg γδ T cells appeared in the presence of Annexin A2 plus IL-2 when compared to IL-2 alone (Fig 6A) . Results obtained from 7 different donors are shown in Figure 6B , indicating statistically significant increase of proliferating Vδ2 neg γδ T cells with Annexin A2. Moreover, the effect of Annexin A2 was specific as Annexin A6 had no effect (Fig. 6C ), in agreement with the results obtained with JRT3 73R9 activation and SPR. This prompted us to try to derive new Annexin A2-specific Vδ2 neg γδ T cell clones. From 72 Vδ2 neg γδ T cell clones expanded polyclonally from three different healthy donors, two clones were able to react to Annexin A2. Interestingly, one of them also reacted to Annexin A6, suggesting the recognition by this clone of a region shared by both Annexins. Using anti-Vδ and anti-Vγ TCR chain antibodies and flow cytometry analysis, we showed that one clone (# 24.2) expressed a Vδ3 TCR (the Vγ chain could not be determined using the panel of available antibodies but was neither Vγ4, Vγ8 nor Vγ9), and the other one (# 33.20) expressed a Vγ4Vδ1 TCR. These results indicate that Annexin A2 specificity is not restricted to the 73R9 TCR nor to Vγ8Vδ3 TCRs.
Discussion:
Because they are able to react to infected, activated or transformed cells, and are involved in host response to diverse situations of stress, γδ T cells are considered to be important players in lymphoid stress surveillance. However, the nature of the cellular dysregulation events that they respond to and the specific molecular stress stimuli that trigger their activation remain poorly understood. In particular, identification of the molecular signals associated with these dysregulations and specifically recognized by the γδ TCR is still limited. As a contribution to this knowledge, we characterized Annexin A2 translocation to the cell surface as a common molecular stress signal recognized by a Vγ8Vδ3 TCR.
The Vγ8Vδ3 γδ T cell clone 73R9 used in this study is representative of a panel of Vδ2 neg γδ T cells previously described to recognize a large panel of B lymphoma cell lines through an atypical ILT-2/HLA axis (19) . We show here that stressed glioblastoma cells can also activate clone 73R9. Interestingly, different molecular mechanisms mediated recognition of distinct Submission PDF target cells. γδ T cell HLA molecules recognize ILT2 on B lymphoma cells and the Vγ8Vδ3 TCR is not (or weakly) involved in this process. In contrast, the TCR recognizes Annexin A2 on glioblastoma cells and ILT2 is not involved. The same γδ T cells can thus recognize different types of cellular dysregulation through distinct molecular pathways, making them able to integrate several and potentially separate contextual signals, in order for them to enlarge their functional diversity and responses to different situations.
Here, we identify Annexin A2 as the antigen targeted by FMS-01 mAb that specifically inhibited Vγ8Vδ3 TCR-mediated recognition of glioblastoma cells. Together with the observation that purified Annexin A2 was able to activate the Vγ8Vδ3 TCR specifically, this result demonstrates that Annexin A2 is critical for Vγ8Vδ3 TCR-dependent recognition of target cells. Annexin A2 belongs to the evolutionary ancient family Ca 2+regulated phospholipid-binding annexin proteins (22) . Annexin A2 is present in the cytoplasm, associated with intracellular membranes of different organelles and with the internal or extracellular face of plasma membrane. It participates in a variety of membrane-related functions (endocytosis, exocytosis, membrane repair) in response to diverse cellular fluctuations including Ca 2+ influx, pH variation, membrane phospholipid composition and its own post-translational modification. It can exist as a monomer or as heterotetrameric complexes with the S100A10 protein, which enhances its membrane phospholipid binding affinity. In our hands, the highest expression of Annexin A2 observed at the cell surface was achieved by placing cells under hypoxia, probably because it combines both membrane translocation and an increase in Annexin A2 gene expression which has been shown to be dependent on HIF-1 (23) . Cellular reoxygenation after hypoxia is followed by ROS burst, and inhibiting ROS production using antioxidant NAC decreased stress-induced Annexin A2 surface expression. Oxidative stress could thus be a common pathway leading to Annexin A2 membrane translocation and γδ T cell activation since NAC also decreased heat shock and high confluence-induced Annexin A2 expression.
Several features of Annexin A2 fulfil what we can expect from a canonical ligand of a Vδ2 neg γδ TCR. First, Annexin A2 is overexpressed in many cancer cells including glioblastoma where it correlates positively with histologic grade and central nervous system dissemination (24) . Secondly, despite the absence of a transmembrane domain, intracellular Annexin A2 can swiftly translocate to cell surface upon stress signals (25) in agreement with the increase of FMS-01 binding on glioblastoma cells treated for only 30 minutes at 42°C. In endothelial cells, Annexin A2 translocation is obtained, in vitro but also in vivo, within minutes in response to heat stress, thrombin exposure or hypoxia and relies on Annexin A2 phosphorylation (21) (22) (23) . Thirdly, consistent with the γδ T cell responses to tissue injury (26) Annexin A2 plays a role in membrane repair and wound healing (27) , which is supposedly due to an intracellular rise in Ca 2+ upon membrane damage (28) . Fourthly, in agreement with 73R9 TCR recognition of CMV-infected cells, CMV-infection has been shown to induce Annexin A2 phosphorylation which is necessary for translocation to cell surface and to further enhance CMV infection (29) .
Annexin A2 appears to represent a bona fide stress antigen expressed on the cell surface only upon cellular dysregulation, and able to alert γδ T cells such as 73R9, 24.2 or 33.20 γδ T cells. Annexin A2 specific γδ T cells could thus contribute to lymphoid stress surveillance, a property that has rather been so 545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 Submission PDF far attributed to innate-like invariant γδ T cells (13) . The diversity and low frequency of Annexin A2-specific γδ T cells that we describe in this study suggest that response to Annexin A2 may rather represent an adaptive response requiring clonal expansion in specific situations. This "adaptive lymphoid stress surveillance" would probably be less immediately efficient than the massive response of invariant subsets but could be more rapid than a conventional αβ T cell response because conceivably taking place within stressed tissues.
Annexins and S100 molecules have been previously classified among alarmins (30) because of their ability to induce inflammatory patterns in endothelial cells and macrophages. Annexin A2 could be considered as a γδ T cell alarmin, acting either through cell-cell contact or as soluble form since Annexin A2 can be released in the extracellular microenvironment (31) . It is tempting to imagine that soluble Annexin A2 could alert distant specific γδ T cells and stimulate their proliferation. However, the affinity of Annexins for membrane phospholipids suggests that even when produced in soluble form Annexin A2 probably rapidly binds to proximal cell membranes and act in a membrane-bound fashion. Our results showing an induction of Vδ2 neg γδ T cell proliferation by soluble Annexin A2 should foster further investigations to evaluate the interest of this antigen in immunotherapeutic settings aiming at stimulating γδ T cell control of cancer or infections.
Materials and Methods:
For further details see SI Materials and Methods.
Generation of effector cells.
Human γδ T clone 73R9 (expressing a TCR Vγ8Vδ3) was obtained as previously described in (19) . Reporter cells expressing TCR 73R9 (JRT3-73R9) were generated as previously described (6) Functional assays with stressed cells. Activation of JRT3 transduced with γδ TCRs by tumor cell lines at 1:1 (E:T) ratio was measured by expression of CD69 by flow cytometry. Activation of clone 73R9 was analysed using CD107a mobilization assay or cytokine production. TCR signalling was also analysed by flow cytometry. In some experiments, tumor cells were infected with CMV clinical strain TB40/E for 4 days. Correct infection of the cells was confirmed by cytopathic effect observation. For hypoxic stress, tumor cells were grown in 21% or 0.1% oxygen atmosphere and were released, counted and stained in normoxia. For heat shock assay, cell lines were grown for 48 hours, then detached and incubated at 42°C or 37°C for the indicated times. For all assays, target cells were washed twice before incubation with effector cells in a 1:1 ratio, or before staining with specific mAbs. In some experiments, glioblastoma cell lines were pre-incubated for 1h with 10 mM N-Acetyl-L-Cystein pH-adjusted solution, before stress induction (heat shock) or cell detachment.
Identification of the ligand of FMS-01
Immunoprecipitation with FMS-01 was applied on tumor cell lysates and bands of interest were cut and eluted proteins digested by trypsin for nLC-MS/MS analysis.
Expression of soluble TCR and binding studies Soluble TCR was produced in drosophila cells and binding with proteins analysed by surface plasmon resonance.
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